查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1942518

2026年全球心臟標記檢測市場報告

Cardiac Marker Testing Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，心臟標記檢測市場規模迅速擴張，預計將從2025年的71.9億美元成長到2026年的79.3億美元，複合年成長率達10.3%。過去幾年成長要素包括高靈敏度心臟標記檢測的普及程度有限、對中心檢查室的依賴、心血管疾病患病率的上升、醫療專業人員意識提升以及傳統的手工診斷方法。

預計未來幾年，心臟標記檢測市場將快速成長，到2030年市場規模將達到116.1億美元，複合年成長率（CAGR）為10.0%。預測期內的成長要素包括：自動化和攜帶式心臟標記檢測設備的研發、照護現場技術的日益普及、與數位健康平台的整合、人口老化和心血管風險的上升，以及試劑和試劑盒靈敏度的提高。預測期內的主要趨勢包括：高靈敏度心臟生物標記檢測的日益普及、就地檢驗設施的擴張、自動化分析儀和免疫檢測系統的整合、心臟標記檢測在預防心臟病學中的應用日益廣泛，以及對攜帶式診斷設備的需求不斷成長。

心血管疾病發生率的上升預計將推動未來心臟標記檢測市場的擴張。心血管疾病包括影響心臟和血管的疾病，例如冠狀動脈疾病、心臟衰竭和中風。心血管疾病發生率的上升與不健康的飲食、缺乏運動、吸煙、過量飲酒和空氣污染密切相關。心臟標記檢測透過檢測心肌損傷過程中釋放的生物標記物，在診斷心血管疾病、評估疾病嚴重程度和監測治療效果方面發揮重要作用。例如，根據美國非營利組織美國心臟協會（American Heart Association）的數據顯示，截至2024年1月，經年齡調整後的心血管疾病死亡率將達到每10萬人233.3人，比前一年增加4.0%。因此，心血管疾病發生率的上升正在增強對心臟標記檢測的需求。

心臟標記檢測市場的主要企業正致力於開發技術先進的產品，例如心臟檢測，以提供準確且具有臨床應用價值的心臟健康和功能資訊。心臟檢測是一種診斷測試，透過測量血液和其他檢體中的特定生物標記來評估心臟功能、診斷心血管疾病並評估心臟相關風險。例如，2023年10月，中國醫療設備製造商邁瑞推出了高敏肌鈣蛋白I (hs-cTnI) 和NT-proBNP心臟生物標記檢測。 hs-cTnI檢測展現出高靈敏度、高準確度和高可靠性，從檢測極限到第99百分位基準值上限的檢出率高達93%，且精密度變異係數小於5%。 NT-proBNP檢測也實現了高準確度，變異係數小於5%，並最大限度地減少了常用心血管藥物的影響，從而有助於心臟衰竭的準確診斷和管理。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球心臟標記檢測市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 人工智慧（AI）和自主人工智慧
    • 物聯網、智慧基礎設施和互聯生態系統
  • 主要趨勢
    • 高靈敏度心臟生物標記檢測的應用日益廣泛
    • 擴大就地檢驗設施
    • 自動化分析儀和免疫檢測系統的整合
    • 擴大心臟標記檢測在預防心臟病學的應用
    • 對攜帶式診斷設備的需求不斷成長

第5章 終端用戶產業市場分析

  • 醫院
  • 診斷檢查室
  • 即時偵測設施
  • 學術研究機構
  • 心臟病診所

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球心臟標記檢測市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球心臟標記檢測市場規模、對比及成長率分析
  • 全球心臟標記檢測市場表現：規模與成長，2020-2025年
  • 全球心臟標記檢測市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 依產品
  • 試劑、試劑盒及設備
  • 依生物標誌類型
  • 肌鈣蛋白 I 和 T、肌酸激酶-MB (CK-MB)、利鈉肽、肌紅蛋白、高敏感性 C 反應蛋白和其他生物標記類型
  • 透過使用
  • 檢測實驗室、就地檢驗實驗室、學術機構
  • 按類型細分：試劑和試劑盒
  • 肌鈣蛋白檢測套組、B型鈉尿肽（BNP）檢測套組、肌酸激酶-MB（CK-MB）檢測套組、肌紅蛋白檢測套組及其他心臟生物標記試劑
  • 按類型細分：設備
  • 就地檢驗設備、自動分析儀、免疫檢測系統、攜帶式診斷設備

第10章 區域與國家分析

  • 全球心臟標記檢測市場：區域分析、預測與趨勢（2020-2025年、2025-2030年預測、2035年預測）
  • 全球心臟標記檢測市場：國家、市場表現及預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 心臟標記檢測市場：競爭格局及市場佔有率（2024年）
  • 心臟標記檢測市場：公司估值矩陣
  • 心臟標記檢測市場：公司概況
    • F. Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Danaher Corporation
    • Siemens Healthineers AG

第37章：其他領先和創新企業

  • Laboratory Corporation of America Holdings, Quest Diagnostics Inc., Tosoh Corporation, Guangzhou Wondfo Biotech Co. Ltd., Randox Laboratories Ltd., Getein Biotech Inc., Fujirebio Inc., Mayo Clinic Laboratories, Alere Inc., Nano-Ditech Corporation, Ortho Clinical Diagnostics, QuidelOrtho Corporation, DiaSorin SpA, PerkinElmer Inc., Meso Scale Diagnostics LLC

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年心臟標記檢測市場：提供新機會的國家
  • 2030年心臟標記檢測市場：新興細分市場機會
  • 2030年心臟標記檢測市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME4MCMTA04_G26Q1

Cardiac marker testing involves diagnostic tests that measure specific substances in the blood that indicate stress or damage to the heart. These markers, often proteins or enzymes, are released into the bloodstream when heart muscle is injured and are essential for diagnosing and evaluating conditions such as heart attacks, heart failure, and other cardiac diseases.

The key cardiac marker testing products include reagents, kits, and instruments. Reagents and kits are critical components in cardiac marker testing, containing the required chemicals and materials to conduct diagnostic evaluations. These tests measure biomarkers such as troponin I and T, creatine kinase-MB (CK-MB), natriuretic peptides, myoglobin, high-sensitivity C-reactive protein, and others, and are used in laboratory testing facilities, point-of-care testing sites, and academic institutions.

Tariffs are impacting the cardiac marker testing market by increasing the cost of imported reagents, kits, and diagnostic instruments. Segments such as high-sensitivity troponin test kits and automated analyzers are particularly impacted, with regions like Asia-Pacific and Europe experiencing supply chain challenges and higher operational costs. While tariffs have posed cost pressures, they also encourage local manufacturing, innovation in reagent formulations, and investment in domestic production of diagnostic instruments, thereby strengthening regional capabilities.

The cardiac marker testing market research report is one of a series of new reports from The Business Research Company that provides cardiac marker testing market statistics, including cardiac marker testing industry global market size, regional shares, competitors with a cardiac marker testing market share, detailed cardiac marker testing market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac marker testing industry. This cardiac marker testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cardiac marker testing market size has grown rapidly in recent years. It will grow from $7.19 billion in 2025 to $7.93 billion in 2026 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to limited availability of high-sensitivity cardiac marker tests, reliance on centralized laboratory testing, growing prevalence of cardiovascular diseases, increasing awareness among healthcare providers, conventional manual diagnostic practices.

The cardiac marker testing market size is expected to see rapid growth in the next few years. It will grow to $11.61 billion in 2030 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to development of automated and portable cardiac marker testing devices, rising adoption of point-of-care diagnostics, integration with digital health platforms, growing geriatric population and cardiovascular risk, advancements in reagent and kit sensitivity. Major trends in the forecast period include rising adoption of high-sensitivity cardiac biomarker tests, expansion of point-of-care testing facilities, integration of automated analyzers and immunoassay systems, growing use of cardiac marker testing in preventive cardiology, increasing demand for portable diagnostic devices.

The rising incidence of cardiovascular diseases is anticipated to support the expansion of the cardiac marker testing market going forward. Cardiovascular diseases include disorders affecting the heart and blood vessels, such as coronary artery disease, heart failure, and stroke. The increasing occurrence of cardiovascular diseases is associated with unhealthy diets, physical inactivity, tobacco use, excessive alcohol consumption, and air pollution. Cardiac marker testing plays a vital role in diagnosing cardiovascular conditions, assessing disease severity, and monitoring treatment response by detecting biomarkers released during myocardial injury. For example, in January 2024, according to the American Heart Association, a US-based nonprofit organization, the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000, representing a 4.0% rise compared to the previous year. As a result, the rising incidence of cardiovascular diseases is strengthening demand within the cardiac marker testing market.

Leading companies operating in the cardiac marker testing market are focusing on developing technologically advanced products, such as cardiac assays, to deliver accurate and clinically valuable insights into heart health and function. Cardiac assays are diagnostic tests that measure specific biomarkers in blood or other samples to assess cardiac function, diagnose cardiovascular diseases, and evaluate heart-related risk. For example, in October 2023, Mindray, a China-based medical device company, launched its high-sensitivity troponin I (hs-cTnI) and NT-proBNP cardiac biomarker assays. The hs-cTnI assay demonstrates high sensitivity, precision, and reliability, achieving a 93% detection rate between the limit of detection and the 99th percentile upper reference limit, with an imprecision coefficient of variation below 5%. The NT-proBNP assay delivers high precision with a coefficient of variation of <=5% while minimizing interference from common cardiovascular medications, supporting accurate heart failure diagnosis and management.

In August 2024, VION Biosciences, a US-based life sciences platform company, acquired Ansh Labs for an undisclosed amount. Through this acquisition, VION Biosciences aims to strengthen its footprint in the diagnostics sector, integrate advanced technologies, and expand its immunoassay development offerings. Ansh Labs is a US-based biotechnology company.

Major companies operating in the cardiac marker testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Laboratory Corporation of America Holdings, Quest Diagnostics Inc., Tosoh Corporation, Guangzhou Wondfo Biotech Co. Ltd., Randox Laboratories Ltd., Getein Biotech Inc., Fujirebio Inc., Mayo Clinic Laboratories, Alere Inc., Nano-Ditech Corporation, Ortho Clinical Diagnostics, QuidelOrtho Corporation, DiaSorin S.p.A., PerkinElmer Inc., Meso Scale Diagnostics LLC, Boditech Med Inc., Response Biomedical Corp.

North America was the largest region in the cardiac marker testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac marker testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cardiac marker testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cardiac marker testing market consists of revenues earned by entities by providing services such as homocysteine testing, cardiac stress testing, genetic testing for cardiovascular risk, remote monitoring and telemedicine services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cardiac marker testing market also includes sales of lipoprotein(a) test kits, cardiac biomarker panels, point-of-care testing devices and related products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiac Marker Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses cardiac marker testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cardiac marker testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiac marker testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Reagents And Kits; Instruments
  • 2) By Biomarker Type: Troponin I And T; Creatine Kinase-MB (CK-MB); Natriuretic Peptide; Myoglobin; High-Sensitivity C-Reactive Protein; Other Biomarker Types
  • 3) By Application: Laboratory Testing Facilities; Point-Of-Care Testing Facilities; Academic Institutions
  • Subsegments:
  • 1) By Reagents and Kits: Troponin Test Kits; B-type Natriuretic Peptide (BNP) Test Kits; Creatine Kinase-MB (CK-MB) Test Kits; Myoglobin Test Kits; Other Cardiac Biomarker Reagents
  • 2) By Instruments: Point-Of-Care Testing Devices; Automated Analyzers; Immunoassay Systems; Portable Diagnostic Devices
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG; Laboratory Corporation of America Holdings; Quest Diagnostics Inc.; Tosoh Corporation; Guangzhou Wondfo Biotech Co. Ltd.; Randox Laboratories Ltd.; Getein Biotech Inc.; Fujirebio Inc.; Mayo Clinic Laboratories; Alere Inc.; Nano-Ditech Corporation; Ortho Clinical Diagnostics; QuidelOrtho Corporation; DiaSorin S.p.A.; PerkinElmer Inc.; Meso Scale Diagnostics LLC; Boditech Med Inc.; Response Biomedical Corp.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Cardiac Marker Testing Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Cardiac Marker Testing Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Cardiac Marker Testing Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Cardiac Marker Testing Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Artificial Intelligence & Autonomous Intelligence
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of High-Sensitivity Cardiac Biomarker Tests
    • 4.2.2 Expansion Of Point-Of-Care Testing Facilities
    • 4.2.3 Integration Of Automated Analyzers And Immunoassay Systems
    • 4.2.4 Growing Use Of Cardiac Marker Testing In Preventive Cardiology
    • 4.2.5 Increasing Demand For Portable Diagnostic Devices

5. Cardiac Marker Testing Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Diagnostic Laboratories
  • 5.3 Point-Of-Care Testing Facilities
  • 5.4 Academic And Research Institutions
  • 5.5 Cardiology Clinics

6. Cardiac Marker Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Cardiac Marker Testing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Cardiac Marker Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Cardiac Marker Testing Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Cardiac Marker Testing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Cardiac Marker Testing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Cardiac Marker Testing Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Cardiac Marker Testing Market Segmentation

  • 9.1. Global Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Reagents And Kits, Instruments
  • 9.2. Global Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Troponin I And T, Creatine Kinase-MB (CK-MB), Natriuretic Peptide, Myoglobin, High-Sensitivity C-Reactive Protein, Other Biomarker Types
  • 9.3. Global Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Laboratory Testing Facilities, Point-Of-Care Testing Facilities, Academic Institutions
  • 9.4. Global Cardiac Marker Testing Market, Sub-Segmentation Of Reagents And Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Troponin Test Kits, B-type Natriuretic Peptide (BNP) Test Kits, Creatine Kinase-MB (CK-MB) Test Kits, Myoglobin Test Kits, Other Cardiac Biomarker Reagents
  • 9.5. Global Cardiac Marker Testing Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Point-Of-Care Testing Devices, Automated Analyzers, Immunoassay Systems, Portable Diagnostic Devices

10. Cardiac Marker Testing Market Regional And Country Analysis

  • 10.1. Global Cardiac Marker Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Cardiac Marker Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Cardiac Marker Testing Market

  • 11.1. Asia-Pacific Cardiac Marker Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Cardiac Marker Testing Market

  • 12.1. China Cardiac Marker Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Cardiac Marker Testing Market

  • 13.1. India Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Cardiac Marker Testing Market

  • 14.1. Japan Cardiac Marker Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Cardiac Marker Testing Market

  • 15.1. Australia Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Cardiac Marker Testing Market

  • 16.1. Indonesia Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Cardiac Marker Testing Market

  • 17.1. South Korea Cardiac Marker Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Cardiac Marker Testing Market

  • 18.1. Taiwan Cardiac Marker Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Cardiac Marker Testing Market

  • 19.1. South East Asia Cardiac Marker Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Cardiac Marker Testing Market

  • 20.1. Western Europe Cardiac Marker Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Cardiac Marker Testing Market

  • 21.1. UK Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Cardiac Marker Testing Market

  • 22.1. Germany Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Cardiac Marker Testing Market

  • 23.1. France Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Cardiac Marker Testing Market

  • 24.1. Italy Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Cardiac Marker Testing Market

  • 25.1. Spain Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Cardiac Marker Testing Market

  • 26.1. Eastern Europe Cardiac Marker Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Cardiac Marker Testing Market

  • 27.1. Russia Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Cardiac Marker Testing Market

  • 28.1. North America Cardiac Marker Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Cardiac Marker Testing Market

  • 29.1. USA Cardiac Marker Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Cardiac Marker Testing Market

  • 30.1. Canada Cardiac Marker Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Cardiac Marker Testing Market

  • 31.1. South America Cardiac Marker Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Cardiac Marker Testing Market

  • 32.1. Brazil Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Cardiac Marker Testing Market

  • 33.1. Middle East Cardiac Marker Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Cardiac Marker Testing Market

  • 34.1. Africa Cardiac Marker Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Cardiac Marker Testing Market Regulatory and Investment Landscape

36. Cardiac Marker Testing Market Competitive Landscape And Company Profiles

  • 36.1. Cardiac Marker Testing Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Cardiac Marker Testing Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Cardiac Marker Testing Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

37. Cardiac Marker Testing Market Other Major And Innovative Companies

  • Laboratory Corporation of America Holdings, Quest Diagnostics Inc., Tosoh Corporation, Guangzhou Wondfo Biotech Co. Ltd., Randox Laboratories Ltd., Getein Biotech Inc., Fujirebio Inc., Mayo Clinic Laboratories, Alere Inc., Nano-Ditech Corporation, Ortho Clinical Diagnostics, QuidelOrtho Corporation, DiaSorin S.p.A., PerkinElmer Inc., Meso Scale Diagnostics LLC

38. Global Cardiac Marker Testing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Cardiac Marker Testing Market

40. Cardiac Marker Testing Market High Potential Countries, Segments and Strategies

  • 40.1 Cardiac Marker Testing Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Cardiac Marker Testing Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Cardiac Marker Testing Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer